Is transmission of HIV-1 in non-viraemic serodiscordant couples possible?

Antiviral Therapy

Volumn 13, Issue 5, 2008, Pages 729-732

  Stürmer, Martin ^a   Doerr, Hans W ^a   Berger, Annemarie ^a   Gute, Peter ^b  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^b Infektiologikum   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; ZIDOVUDINE;

ADULT; ANUS INTERCOURSE; ARTICLE; BLOOD SAMPLING; CASE REPORT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFECTION RISK; LYMPHOCYTE COUNT; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; SAFE SEX; SEROCONVERSION; UNSPECIFIED SIDE EFFECT; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS TRANSMISSION;

ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; DISEASE TRANSMISSION, HORIZONTAL; HIV INFECTIONS; HIV SERONEGATIVITY; HIV-1; HOMOSEXUALITY, MALE; HUMANS; MALE; SEXUAL BEHAVIOR; SEXUAL PARTNERS; VIRAL LOAD;

EID: 49949104062     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA 2004; 292:224-236.
2. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med 2000; 342:921-929.
3. Vernazza PL, Troiani L, Flepp, MJ, et al. Potent antiretroviral treatment of HIV-infection results in suppression of the seminal shedding of HIV. The Swiss HIV Cohort Study. AIDS 2000; 14:117-121.
4. Chakraborty H, Sen PK, Helms RW, et al. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS 2001; 15:621-627.
5. Zhang H, Dornadula G, Beumont M, et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998; 339:1803-1809.
6. Staszewski S, Morales-Ramirez J, Tashima KT, et al. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team. N Engl J Med 1999; 341:1865-1873.
7. Sturmer M, Preiser W, Gute P, Nisius G, Doerr HW. Phylogenetic analysis of HIV-1 transmission: pol gene sequences are insufficient to clarify true relationships between patient isolates. AIDS 2004; 18:2109-2113.
8. Hue S, Clewley JP, Cane PA, Pillay D. HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy. AIDS 2004; 18:719-728.
9. Taylor S, Pereira AS. Antiretroviral drug concentrations in semen of HIV-1 infected men. Sex Transm Infect 2001; 77:4-11.
10. Chan DJ. Pathophysiology of HIV-1 in semen: current evidence for compartmentalisation and penetration by antiretroviral drugs. Curr HIV Res 2005; 3:207-222.